Skip to main content
CME logo

CME Group Inc - Class A

Exchange: NASDAQSector: Financial ServicesIndustry: Financial Data & Stock Exchanges

As the world's leading derivatives marketplace, CME Group ( www.cmegroup.com ) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, cryptocurrencies, energy, agricultural products and metals. The company offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing. CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and E-mini are trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. BrokerTec is a trademark of BrokerTec Americas LLC and EBS is a trademark of EBS Group LTD. The S&P 500 Index is a product of S&P Dow Jones Indices LLC ("S&P DJI"). "S&P®", "S&P 500®", "SPY®", "SPX®", US 500 and The 500 are trademarks of Standard & Poor's Financial Services LLC; Dow Jones®, DJIA® and Dow Jones Industrial Average are service and/or trademarks of Dow Jones Trademark Holdings LLC. These trademarks have been licensed for use by Chicago Mercantile Exchange Inc. Futures contracts based on the S&P 500 Index are not sponsored, endorsed, marketed, or promoted by S&P DJI, and S&P DJI makes no representation regarding the advisability of investing in such products. All other trademarks are the property of their respective owners. About Purdue University Purdue University is a public research university leading with excellence at scale. Ranked among top 10 public universities in the United States, Purdue discovers, disseminates and deploys knowledge with a quality and at a scale second to none. More than 106,000 students study at Purdue across multiple campuses, locations and modalities, including more than 57,000 at our main campus locations in West Lafayette and Indianapolis. Committed to affordability and accessibility, Purdue's main campus has frozen tuition 14 years in a row. See how Purdue never stops in the persistent pursuit of the next giant leap — including its integrated, comprehensive Indianapolis urban expansion; the Mitch Daniels School of Business; Purdue Computes; and the One Health initiative — at https://www.purdue.edu/president/strategic-initiatives. Source: Michael Langemeier, [email protected], 765-494-9557 CME-G SOURCE CME Group

Did you know?

Earnings per share grew at a 9.5% CAGR.

Current Price

$305.11

+2.75%

GoodMoat Value

$292.09

4.3% overvalued
Profile
Valuation (TTM)
Market Cap$110.02B
P/E27.36
EV$109.43B
P/B3.83
Shares Out360.60M
P/Sales16.87
Revenue$6.52B
EV/EBITDA18.83

CME Group Inc - Class A (CME) Valuation

GoodMoat Analysis

Based on data as of March 26, 2026

CME Group appears fairly valued relative to its GoodMoat Target, offering a marginal margin of safety. Its P/E multiple is elevated compared to its sector and its own earnings growth, suggesting the market is pricing in its high-quality, stable business model. The valuation is not a clear bargain for a value investor seeking a wide margin of safety.

Read full analysis
The current price of $293.93 is essentially in line with the GoodMoat Target of $292.09, indicating a marginal margin of safety of less than 1%. According to the GoodMoat framework, a margin of safety below 10% is classified as 'Unfavourable', and the 20-40% band is considered 'Favourable'. This places CME in a valuation zone that does not offer a significant discount to its estimated intrinsic value. The forward P/E of 26.4x is notably higher than the typical sector average for financial services, which often trades at lower multiples. While a P/E of 25-26x can be reasonable for a company growing earnings at 50%, CME's revenue growth is 8.0% YoY, suggesting the multiple is pricing in its exceptional profitability and stability rather than high growth. The stock's quality is high, evidenced by a stellar 64.9% operating margin and 61.7% profit margin, but the current valuation reflects this quality fully, leaving little room for error. For a value investor, the stock is not cheap; it is fairly valued relative to its own quality, trading near its perceived fair value with a minimal margin of safety.

CME Fair Value Estimate

$292.094.3% overvalued

Blended fair value estimate based on DCF, Graham Number, and earnings-based models.

CME Valuation Metrics

FCF$4.19B
FCF Growth Rate9.54%
EPS Growth (CAGR)9.54%
WACC10.00%

CME Valuation & Fair Value Analysis

CME Group Inc - Class A (CME) valuation analysis using multiple fair value methodologies. GoodMoat calculates a blended fair value target using discounted cash flow (DCF) analysis, the Graham Number, and earnings-based valuation models.

The GoodMoat Fair Value target for CME Group Inc - Class A is $292.09. The current stock price is $305.11, suggesting the stock is 4.5% overvalued.

The price-to-earnings (P/E) ratio is 27.36. Price-to-book ratio is 3.83. Price-to-sales ratio is 16.87. Enterprise value to EBITDA is 18.83. PEG ratio is 0.77.

GoodMoat's valuation models include the Graham Number (based on EPS and book value), an earnings-based model (discounted future EPS), and a PEG-adjusted valuation. The three models are averaged to produce a blended fair value estimate. Use these tools alongside the DCF calculator and reverse DCF to form a comprehensive view of CME Group Inc - Class A's intrinsic value.